(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -12.07%324.81M | 4.78%2.38B | 24.34%1.59B | 30.27%1.01B | 36.32%369.39M | 49.54%2.27B | 48.97%1.28B | 45.33%776.88M | 34.82%270.98M | 40.97%1.52B |
Operating income | -12.07%324.81M | 4.78%2.38B | 24.34%1.59B | 30.27%1.01B | 36.32%369.39M | 49.54%2.27B | 48.97%1.28B | 45.33%776.88M | 34.82%270.98M | 40.97%1.52B |
Cost of sales | ---- | -17.74%-1.4B | ---- | -41.44%-564.28M | ---- | -51.93%-1.19B | ---- | -49.99%-398.94M | ---- | -48.68%-781M |
Operating expenses | -22.26%-218.16M | -17.74%-1.4B | -39.02%-892.46M | -41.44%-564.28M | -36.29%-178.43M | -51.93%-1.19B | -48.98%-641.98M | -49.99%-398.94M | -34.51%-130.92M | -48.68%-781M |
Gross profit | -44.15%106.65M | -9.44%979.39M | 9.49%694.62M | 18.48%447.8M | 36.34%190.96M | 47.00%1.08B | 48.96%634.41M | 40.72%377.94M | 35.11%140.06M | 33.61%735.68M |
Selling expenses | -9.13%-5.85M | -36.70%-24.62M | -47.96%-18.33M | -44.99%-11.87M | -35.84%-5.36M | -12.73%-18.01M | -6.71%-12.39M | -12.84%-8.18M | -23.43%-3.95M | -23.75%-15.97M |
Administrative expenses | 3.46%-71.96M | 1.13%-296.48M | 1.71%-229.24M | -0.58%-159.7M | -16.62%-74.54M | -13.45%-299.87M | -19.27%-233.22M | -17.06%-158.78M | 4.75%-63.92M | -24.99%-264.32M |
Research and development expenses | 16.82%-22.97M | -24.20%-96.85M | -55.11%-77.64M | -123.42%-56.93M | -124.68%-27.61M | -63.30%-77.99M | -42.93%-50.05M | -16.56%-25.48M | -24.40%-12.29M | 5.73%-47.76M |
Profit from asset sales | ---- | ---- | -11.25%-66.97K | ---- | ---- | ---- | -2,073.25%-60.2K | ---- | ---- | ---- |
Revaluation surplus | -414.92%-310.01M | -186.71%-288.81M | -146.03%-108.51M | -251.36%-198.77M | 156.68%98.44M | 165.77%333.07M | 194.45%235.77M | 247.74%131.32M | 4,149.64%38.35M | 128.98%125.32M |
-Changes in the fair value of other assets | -414.92%-310.01M | -186.71%-288.81M | -146.03%-108.51M | -251.36%-198.77M | 156.68%98.44M | 165.77%333.07M | 194.45%235.77M | 247.74%131.32M | 4,149.64%38.35M | 128.98%125.32M |
Impairment and provision | -1,021.68%-28.13M | ---- | -12.02%-8.61M | ---- | -212.08%-2.51M | ---- | -21.55%-7.68M | ---- | 60.56%-803.68K | ---- |
-Other impairment is provision | -1,021.68%-28.13M | ---- | -12.02%-8.61M | ---- | -212.08%-2.51M | ---- | -21.55%-7.68M | ---- | 60.56%-803.68K | ---- |
Special items of operating profit | 14.85%13.62M | 5.66%240.52M | 15.66%27.03M | -17.14%99.77M | 20.84%11.86M | 100.67%227.64M | -42.98%23.37M | 269.45%120.41M | -49.06%9.82M | 257.63%113.44M |
Operating profit | -269.34%-321.02M | -58.82%513.16M | -53.07%273.52M | -72.49%120.3M | 80.54%189.57M | 92.80%1.25B | 99.56%582.85M | 151.03%437.23M | 162.45%105M | 78.55%646.39M |
Financing cost | 12.95%28.01M | 12.28%-3.14M | -12.12%118.57M | 2.66%-1.68M | -28.79%24.8M | 9.59%-3.58M | 1,383.04%134.93M | -12.29%-1.73M | -48.63%34.82M | -12.52%-3.96M |
Share of profits of associates | ---- | -14.05%-3.07M | ---- | -379.71%-1.68M | ---- | -531.69%-2.69M | ---- | ---350K | ---- | ---426K |
Special items of earning before tax | -198.66%-121.74K | ---- | -100.69%-99.76K | ---- | 40.53%-40.76K | ---- | 1,261.14%14.43M | ---- | 98.18%-68.55K | ---- |
Earning before tax | -236.77%-293.13M | -59.12%506.95M | -46.47%391.99M | -73.13%116.94M | 53.36%214.33M | 93.15%1.24B | 161.22%732.2M | 152.07%435.15M | 34.34%139.76M | 79.08%642M |
Tax | 174.26%19.77M | 30.82%-115.4M | 35.01%-65.79M | 57.65%-27.43M | -78.92%-26.62M | -94.89%-166.8M | -204.07%-101.23M | -231.48%-64.76M | -36.04%-14.88M | -82.32%-85.59M |
After-tax profit from continuing operations | -245.63%-273.36M | -63.52%391.55M | -48.30%326.2M | -75.83%89.51M | 50.31%187.71M | 92.88%1.07B | 155.44%630.97M | 141.93%370.38M | 34.13%124.88M | 78.59%556.42M |
Earning after tax | -245.63%-273.36M | -63.52%391.55M | -48.30%326.2M | -75.83%89.51M | 50.31%187.71M | 92.88%1.07B | 155.44%630.97M | 141.93%370.38M | 34.13%124.88M | 78.59%556.42M |
Minority profit | -2,201.76%-1.14M | -414.66%-5.44M | -32.13%-1.4M | -52.04%-1.12M | 89.40%-49.58K | -1.34%-1.06M | -6.41%-1.06M | -14.64%-736K | -81.86%-467.84K | 24.75%-1.04M |
Profit attributable to shareholders | -244.98%-272.22M | -63.04%396.99M | -48.17%327.6M | -75.58%90.63M | 49.79%187.76M | 92.71%1.07B | 154.85%632.03M | 141.40%371.12M | 34.27%125.35M | 78.13%557.46M |
Basic earnings per share | -244.00%-0.36 | -63.19%0.53 | -47.62%0.44 | -75.71%0.17 | 4.17%0.25 | 33.33%1.44 | 23.53%0.84 | 62.79%0.7 | -14.29%0.24 | 9.09%1.08 |
Diluted earnings per share | -244.00%-0.36 | -62.94%0.53 | -47.62%0.44 | -75.36%0.17 | 4.17%0.25 | 33.64%1.43 | 25.37%0.84 | 64.29%0.69 | -11.11%0.24 | 9.18%1.07 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | KPMG | -- | -- | -- | KPMG | -- | -- | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data